1. Home
  2. EVOK vs IPDN Comparison

EVOK vs IPDN Comparison

Compare EVOK & IPDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVOK
  • IPDN
  • Stock Information
  • Founded
  • EVOK 2007
  • IPDN 2003
  • Country
  • EVOK United States
  • IPDN United States
  • Employees
  • EVOK N/A
  • IPDN N/A
  • Industry
  • EVOK Biotechnology: Pharmaceutical Preparations
  • IPDN EDP Services
  • Sector
  • EVOK Health Care
  • IPDN Technology
  • Exchange
  • EVOK Nasdaq
  • IPDN Nasdaq
  • Market Cap
  • EVOK 5.4M
  • IPDN 5.4M
  • IPO Year
  • EVOK 2013
  • IPDN 2013
  • Fundamental
  • Price
  • EVOK $5.12
  • IPDN $2.24
  • Analyst Decision
  • EVOK
  • IPDN
  • Analyst Count
  • EVOK 0
  • IPDN 0
  • Target Price
  • EVOK N/A
  • IPDN N/A
  • AVG Volume (30 Days)
  • EVOK 104.5K
  • IPDN 2.0M
  • Earning Date
  • EVOK 08-14-2025
  • IPDN 08-14-2025
  • Dividend Yield
  • EVOK N/A
  • IPDN N/A
  • EPS Growth
  • EVOK N/A
  • IPDN N/A
  • EPS
  • EVOK N/A
  • IPDN N/A
  • Revenue
  • EVOK $12,794,859.00
  • IPDN $6,459,379.00
  • Revenue This Year
  • EVOK $57.82
  • IPDN N/A
  • Revenue Next Year
  • EVOK $59.12
  • IPDN N/A
  • P/E Ratio
  • EVOK N/A
  • IPDN N/A
  • Revenue Growth
  • EVOK 70.02
  • IPDN N/A
  • 52 Week Low
  • EVOK $1.94
  • IPDN $0.97
  • 52 Week High
  • EVOK $12.32
  • IPDN $11.20
  • Technical
  • Relative Strength Index (RSI)
  • EVOK 55.77
  • IPDN 51.04
  • Support Level
  • EVOK $4.61
  • IPDN $2.10
  • Resistance Level
  • EVOK $5.70
  • IPDN $2.27
  • Average True Range (ATR)
  • EVOK 0.52
  • IPDN 0.21
  • MACD
  • EVOK -0.03
  • IPDN -0.01
  • Stochastic Oscillator
  • EVOK 71.01
  • IPDN 54.64

About EVOK Evoke Pharma Inc.

Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.

About IPDN Professional Diversity Network Inc.

Professional Diversity Network Inc is engaged in providing access to networking, training, educational and employment services to its registered users. It has three operating segments: the TalentAlly Network segment, which maintains and operates job board software and hosts career fairs; the National Association of Professional Women (NAPW) segment, which is a women-only professional networking organization; the RemoteMore segment; and Corporate Overhead. The company generates majority of its revenue from TalentAlly Network Segment.

Share on Social Networks: